222 related articles for article (PubMed ID: 19080648)
1. [Testosterone replacement in hypogonadotropic hypogonadal young male improves insulin sensitivity].
Mao JF; Wu XY; Li NS; Lu SY; Jing ZM; Shi YF
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2550-2. PubMed ID: 19080648
[TBL] [Abstract][Full Text] [Related]
2. Testosterone replacement therapy improves insulin sensitivity and decreases high sensitivity C-reactive protein levels in hypogonadotropic hypogonadal young male patients.
Wu XY; Mao JF; Lu SY; Zhang Q; Shi YF
Chin Med J (Engl); 2009 Dec; 122(23):2846-50. PubMed ID: 20092788
[TBL] [Abstract][Full Text] [Related]
3. Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.
Tripathy D; Shah P; Lakshmy R; Reddy KS
Horm Metab Res; 1998 Oct; 30(10):642-5. PubMed ID: 9851674
[TBL] [Abstract][Full Text] [Related]
4. [Hypogonadism may cause insulin resistance in young males].
Mao JF; Wu XY; Li NS; Shi YF
Zhonghua Nan Ke Xue; 2006 Jul; 12(7):612-4. PubMed ID: 16894938
[TBL] [Abstract][Full Text] [Related]
5. Serum adiponectin levels in hypogonadal males: influence of testosterone replacement therapy.
Lanfranco F; Zitzmann M; Simoni M; Nieschlag E
Clin Endocrinol (Oxf); 2004 Apr; 60(4):500-7. PubMed ID: 15049966
[TBL] [Abstract][Full Text] [Related]
6. Serum testosterone and bioavailable testosterone correlate with age and body size in hypogonadal men treated with testosterone undecanoate (1000 mg IM--Nebido).
Moisey R; Swinburne J; Orme S
Clin Endocrinol (Oxf); 2008 Oct; 69(4):642-7. PubMed ID: 18394021
[TBL] [Abstract][Full Text] [Related]
7. [Non-alcoholic fatty liver, high sensitivity C reactive protein and insulin resistance].
Zhou WD; Yang YL; Che ZH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 33(7):565-70. PubMed ID: 18667766
[TBL] [Abstract][Full Text] [Related]
8. HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism.
Bolu E; Sonmez A; Tapan S; Taslipinar A; Aydogdu A; Meric C; Basaran Y; Uckaya G; Serdar M; Kurt I; Azal O
Horm Metab Res; 2013 Jun; 45(6):443-8. PubMed ID: 23613012
[TBL] [Abstract][Full Text] [Related]
9. Effect of sex hormone treatment on circulating adiponectin and subforms in Turner and Klinefelter syndrome.
Høst C; Bojesen A; Frystyk J; Flyvbjerg A; Christiansen JS; Gravholt CH
Eur J Clin Invest; 2010 Mar; 40(3):211-9. PubMed ID: 20100236
[TBL] [Abstract][Full Text] [Related]
10. [Postprandial changes of blood lipid after ordinary Chinese diet and the influencing factors thereof].
Fu ZF; Liu ML
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):260-2. PubMed ID: 19552844
[TBL] [Abstract][Full Text] [Related]
11. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
[TBL] [Abstract][Full Text] [Related]
12. Is hypoandrogenemia a component of metabolic syndrome in males?
Singh SK; Goyal R; Pratyush DD
Exp Clin Endocrinol Diabetes; 2011 Jan; 119(1):30-5. PubMed ID: 20690073
[TBL] [Abstract][Full Text] [Related]
13. Change of visfatin, C-reactive protein concentrations, and insulin sensitivity in patients with hyperthyroidism.
Chu CH; Lee JK; Wang MC; Lu CC; Sun CC; Chuang MJ; Lam HC
Metabolism; 2008 Oct; 57(10):1380-3. PubMed ID: 18803942
[TBL] [Abstract][Full Text] [Related]
14. Left ventricular dysfunction in Klinefelter syndrome is associated to insulin resistance, abdominal adiposity and hypogonadism.
Andersen NH; Bojesen A; Kristensen K; Birkebaek NH; Fedder J; Bennett P; Christiansen JS; Gravholt CH
Clin Endocrinol (Oxf); 2008 Nov; 69(5):785-91. PubMed ID: 18248650
[TBL] [Abstract][Full Text] [Related]
15. Androgenetic alopecia and insulin resistance in young men.
González-González JG; Mancillas-Adame LG; Fernández-Reyes M; Gómez-Flores M; Lavalle-González FJ; Ocampo-Candiani J; Villarreal-Pérez JZ
Clin Endocrinol (Oxf); 2009 Oct; 71(4):494-9. PubMed ID: 19094069
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and the effect of testosterone replacement.
Sonmez A; Haymana C; Aydogdu A; Tapan S; Basaran Y; Meric C; Baskoy K; Dinc M; Yazici M; Taslipinar A; Barcin C; Yilmaz MI; Bolu E; Azal O
Endocr J; 2015; 62(7):605-13. PubMed ID: 25924666
[TBL] [Abstract][Full Text] [Related]
17. Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes.
Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Sandhu S; Green K; Makdissi A; Hejna J; Chaudhuri A; Punyanitya M; Dandona P
Diabetes Care; 2016 Jan; 39(1):82-91. PubMed ID: 26622051
[TBL] [Abstract][Full Text] [Related]
18. Elevated high sensitivity C-reactive protein levels in aging men with low testosterone.
Kaplan SA; Johnson-Levonas AO; Lin J; Shah AK; Meehan AG
Aging Male; 2010 Jun; 13(2):108-12. PubMed ID: 20001470
[TBL] [Abstract][Full Text] [Related]
19. Hypogonadotrophic hypogonadism in type 2 diabetes.
Dandona P; Dhindsa S; Chaudhuri A; Bhatia V; Topiwala S
Aging Male; 2008 Sep; 11(3):107-17. PubMed ID: 18821286
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism.
Sonmez A; Haymana C; Bolu E; Aydogdu A; Tapan S; Serdar M; Altun B; Barcin C; Taslipinar A; Meric C; Uckaya G; Kutlu M
Eur J Endocrinol; 2011 May; 164(5):759-64. PubMed ID: 21325471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
